Molecular Epidemiology of NHL and CLL
Molecular Epidemiology of NHL and CLL
批准号:
6617495
负责人:
JAMES R CERHAN
金额:
$60.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2008-03-31
关键词:
cancer risk case history chronic lymphocytic leukemia clinical research cytokine data collection methodology /evaluation dietary constituent disease /disorder etiology early experience environmental exposure gene environment interaction gene expression genetic polymorphism genetic susceptibility genotype human genetic material tag human subject microarray technology molecular pathology neoplasm /cancer epidemiology neoplasm /cancer genetics nonHodgkin's lymphoma pesticides polymerase chain reaction questionnaires ultraviolet spectrometry
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Non-Hodgkin Lymphoma (NHL) incidence and mortality have been rapidly increasing over the past 50 years, and these trends are largely unexplained. Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western world, and appears to be biologically related to small lymphocytic NHL. Some of the highest incidence and mortality rates in the world occur in the upper midwestern United States. In this study, we propose to systematically test hypotheses regarding medical history, pesticide/farming exposures, diet and early life factors that have been raised by recent research as being important in the etiology of NHL or CLL. We will also test novel hypotheses that genes with functional, common variant polymorphisms involved in immune function and regulation are associated with risk of NHL or CLL; these include genes encoding inflammatory and regulatory cytokines (IL-1A, IL-1B, IL-1RN, TNFalpha, Thl/Th2 cytokines (LTA, INFgamma, IL-4, IL- 4RA, IL-6, IL-IO, IL-13), and chemokines (IL-8, SDF-1, CCR2, CCR5). We will also evaluate the extent that measured environmental factors might modify or confound any observed association between these candidate genes and risk of NHL and CLL. Furthermore, in secondary analyses, we will evaluate gene-gene (within and between pathways), as well as selected gene-environment interactions. We will also begin to address the issue of etiologic heterogeneity for the most common subtypes of NHL. To test these hypotheses, we propose a clinic-based case-control study. We will enroll incident cases of NHL (N=914) and CLL (N=238) diagnosed at the Mayo Clinic over a 4.7-year time period who are residents of Minnesota, Iowa or Wisconsin at the time of diagnosis. All cases will be reviewed by a single hematopathologist and classified into the WHO classification system, and frozen and paraffin tissue will be banked. Cases will be compared to 1,152 clinic-based controls frequency matched on age, sex, and county of residence. Participants will complete structured self-administered questionnaires and provide a blood sample for DNA and serum. There is generally excellent statistical power to test the a priori hypotheses of interest. We have assembled an interdisciplinary research team for this study, and this study will create an outstanding research resource. In summary, we will evaluate critical hypotheses regarding environmental and genetic risk factors for NHL and CLL, and should greatly contribute to our understanding the causes and possible prevention of these cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)
-
批准号:10626269
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2022
-
负责人:JAMES R CERHAN
-
依托单位:
Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma
-
批准号:10219978
-
项目类别:
-
资助金额:$65.74万
-
财政年份:2017
-
负责人:JAMES R CERHAN
-
依托单位:
Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma
-
批准号:9751227
-
项目类别:
-
资助金额:$63.77万
-
财政年份:2017
-
负责人:JAMES R CERHAN
-
依托单位:
Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma
-
批准号:9380363
-
项目类别:
-
资助金额:$66.76万
-
财政年份:2017
-
负责人:JAMES R CERHAN
-
依托单位:
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
-
批准号:10381614
-
项目类别:
-
资助金额:$193.81万
-
财政年份:2015
-
负责人:JAMES R CERHAN
-
依托单位:
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
-
批准号:9334403
-
项目类别:
-
资助金额:$4.53万
-
财政年份:2015
-
负责人:JAMES R CERHAN
-
依托单位:
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
-
批准号:9096776
-
项目类别:
-
资助金额:$225.12万
-
财政年份:2015
-
负责人:JAMES R CERHAN
-
依托单位:
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
-
批准号:9379101
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2015
-
负责人:JAMES R CERHAN
-
依托单位:
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
-
批准号:10593053
-
项目类别:
-
资助金额:$193.81万
-
财政年份:2015
-
负责人:JAMES R CERHAN
-
依托单位:
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
-
批准号:8888571
-
项目类别:
-
资助金额:$240.59万
-
财政年份:2015
-
负责人:JAMES R CERHAN
-
依托单位:
P3 - Biology and Epidemiology of APRIL and Blys in B-cell and NHL
-
批准号:8076890
-
项目类别:
-
资助金额:$42.55万
-
财政年份:2010
-
负责人:JAMES R CERHAN
-
依托单位:
Molecular Epidemiology of NHL and CLL
-
批准号:7930734
-
项目类别:
-
资助金额:$59.75万
-
财政年份:2009
-
负责人:JAMES R CERHAN
-
依托单位:
Molecular Epidemiology of non-Hodgkin Lymphoma Survival
-
批准号:7894772
-
项目类别:
-
资助金额:$62.14万
-
财政年份:2009
-
负责人:JAMES R CERHAN
-
依托单位:
Molecular Epidemiology of non-Hodgkin Lymphoma Survival
-
批准号:7649698
-
项目类别:
-
资助金额:$60.91万
-
财政年份:2009
-
负责人:JAMES R CERHAN
-
依托单位:
Biology and Epidemiology of APRIL and Blys in B-cell and NHL
-
批准号:7254594
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2007
-
负责人:JAMES R CERHAN
-
依托单位:
Molecular Epidemiology of NHL and CLL
-
批准号:6873737
-
项目类别:
-
资助金额:$62.54万
-
财政年份:2003
-
负责人:JAMES R CERHAN
-
依托单位:
Molecular Epidemiology of NHL and CLL
-
批准号:8289640
-
项目类别:
-
资助金额:$56.26万
-
财政年份:2003
-
负责人:JAMES R CERHAN
-
依托单位:
Molecular Epidemiology of NHL and CLL
-
批准号:7454646
-
项目类别:
-
资助金额:$62.97万
-
财政年份:2003
-
负责人:JAMES R CERHAN
-
依托单位:
Molecular Epidemiology of NHL and CLL
-
批准号:8120507
-
项目类别:
-
资助金额:$58.45万
-
财政年份:2003
-
负责人:JAMES R CERHAN
-
依托单位:
FIRCA Breast Cancer Case-Control Study in Slovakia
-
批准号:6581085
-
项目类别:
-
资助金额:$3.46万
-
财政年份:2003
-
负责人:JAMES R CERHAN
-
依托单位:
海外基金